Biliary Tract or Colorectal Cancer With Her2-positive/Mutated
1 clinical trials · Condition
◉ Watch Biliary Tract or Colorectal Cancer With Her2-positive/Mutated
| Record | Firm | Date |
|---|---|---|
| A Clinical Study of SPH5030 Tablets in the Treatment of Her2-positive/Mutated Biliary Tract OR Colorectal Cancer Patients. (NCT06434597) | Shanghai Pharmaceuticals Holding Co., Ltd | 2024-07-17 |
Track Biliary Tract or Colorectal Cancer With Her2-positive/Mutated automatically
Every clearance here is in the API, with alerts when new ones post.